Charles Schwab’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-40,827
| Closed | -$256K | – | 3695 |
|
2022
Q1 | $256K | Hold |
40,827
| – | – | ﹤0.01% | 3262 |
|
2021
Q4 | $455K | Hold |
40,827
| – | – | ﹤0.01% | 3179 |
|
2021
Q3 | $667K | Buy |
40,827
+4,181
| +11% | +$68.3K | ﹤0.01% | 3041 |
|
2021
Q2 | $680K | Buy |
36,646
+19,566
| +115% | +$363K | ﹤0.01% | 3064 |
|
2021
Q1 | $258K | Buy |
17,080
+5,479
| +47% | +$82.8K | ﹤0.01% | 3281 |
|
2020
Q4 | $375K | Buy |
+11,601
| New | +$375K | ﹤0.01% | 3081 |
|